Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-071467·DODGE & COX
Schedule 13G ownership disclosure
NEUROCRINE BIOSCIENCES INC COM
Common Stock · CUSIP: 64125C109
Event date: 2025-03-31
- Filing-level shares
- 5,534,624
- Percent of class
- 5.6%
- Dodge & Cox
Shares: 5,534,624 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-071467
- Form type
- SCHEDULE 13G
- Filer
- DODGE & COX
- CIK
- CIK 200217
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership